129 related articles for article (PubMed ID: 29607815)
41. Hürthle cell adenoma of the thyroid: in 32 consecutive cases.
Guadagni S; Francavilla S; Agnifili A; De Bernardinis G; Mariani G; Carboni M
J R Coll Surg Edinb; 1996 Aug; 41(4):246-9. PubMed ID: 8772075
[TBL] [Abstract][Full Text] [Related]
42. Tall cell variant of papillary thyroid carcinoma: cytologic features and differential diagnostic considerations.
Bocklage T; DiTomasso JP; Ramzy I; Ostrowski ML
Diagn Cytopathol; 1997 Jul; 17(1):25-9. PubMed ID: 9218899
[TBL] [Abstract][Full Text] [Related]
43. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
44. The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience.
Rossi ED; Martini M; Straccia P; Raffaelli M; Pennacchia I; Marrucci E; Lombardi CP; Pontecorvi A; Fadda G
Eur J Endocrinol; 2013 Nov; 169(5):649-55. PubMed ID: 23985131
[TBL] [Abstract][Full Text] [Related]
45. [Hurthle cell neoplasm: our experience].
Cristofaro MG; Vescio G; Fava MG; Aversa C; Amantea M; Giudice M
Ann Ital Chir; 2004; 75(6):663-8. PubMed ID: 15960361
[TBL] [Abstract][Full Text] [Related]
46. Assessment of proliferative activity of thyroid Hürthle cell tumors using PCNA, Ki-67 and AgNOR methods.
Augustynowicz A; Dziecioł J; Barwijuk-Machała M; Dadan J; Puchalski Z; Sulkowski S
Folia Histochem Cytobiol; 2004; 42(3):165-8. PubMed ID: 15493577
[TBL] [Abstract][Full Text] [Related]
47. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
48. Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.
Lee J; Yi S; Kang YE; Chang JY; Kim JT; Sul HJ; Kim JO; Kim JM; Kim J; Porcelli AM; Kim KS; Shong M
Oncotarget; 2016 Nov; 7(48):79117-79130. PubMed ID: 27816963
[TBL] [Abstract][Full Text] [Related]
49. Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification.
Ustun B; Chhieng D; Van Dyke A; Carling T; Holt E; Udelsman R; Adeniran AJ
Cancer Cytopathol; 2014 Jul; 122(7):536-45. PubMed ID: 24753500
[TBL] [Abstract][Full Text] [Related]
50. Intranuclear cytoplasmic inclusions and nuclear grooves in fine needle aspiration smears of papillary thyroid carcinoma and its variants: advantage of the count under an oil-immersion objective over a high-power objective.
Das DK; Sharma PN
Anal Quant Cytol Histol; 2005 Apr; 27(2):83-94. PubMed ID: 15913201
[TBL] [Abstract][Full Text] [Related]
51. Thyroid follicular carcinoma: sonographic features of 50 cases.
Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
[TBL] [Abstract][Full Text] [Related]
52. Hürthle Cells Adenoma of the Thyroid with Post-surgical Implants in the Neck: Clinical, Morphological, and Molecular Analysis of Three Cases.
Bongiovanni M; Uccella S; Giovanella L; Molinari F; Frattini M; Dionigi G; Piantanida E; Nobile A; Sessa F; La Rosa S
Endocr Pathol; 2016 Dec; 27(4):338-345. PubMed ID: 27108352
[TBL] [Abstract][Full Text] [Related]
53. The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease.
Kauffmann PR; Dejax C; de Latour M; Dauplat J
Eur J Surg Oncol; 2004 Sep; 30(7):786-9. PubMed ID: 15296995
[TBL] [Abstract][Full Text] [Related]
54. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
[TBL] [Abstract][Full Text] [Related]
55. Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm".
Kim ES; Nam-Goong IS; Gong G; Hong SJ; Kim WB; Shong YK
Korean J Intern Med; 2003 Jun; 18(2):94-7. PubMed ID: 12872446
[TBL] [Abstract][Full Text] [Related]
56. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
[TBL] [Abstract][Full Text] [Related]
57. Thyroid tumors: cytomorphology of Hürthle cell tumors, including an uncommon papillary variant.
Kaur A; Jayaram G
Diagn Cytopathol; 1993; 9(2):135-7. PubMed ID: 8513705
[TBL] [Abstract][Full Text] [Related]
58. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms.
Lubitz CC; Faquin WC; Yang J; Mekel M; Gaz RD; Parangi S; Randolph GW; Hodin RA; Stephen AE
Thyroid; 2010 Jan; 20(1):25-31. PubMed ID: 20025540
[TBL] [Abstract][Full Text] [Related]
59. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions.
Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ
Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417
[TBL] [Abstract][Full Text] [Related]
60. Papillary Hürthle cell carcinoma (Warthin-like tumor) of the thyroid. Report of a case with fine needle aspiration findings.
Vasei M; Kumar PV; Malekhoseini SA; Kadivar M
Acta Cytol; 1998; 42(6):1437-40. PubMed ID: 9850656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
